Red Light Therapy

iVitality MD Houston offers red light therapy (photobiomodulation) using red and near-infrared wavelengths to support cellular energy production, collagen synthesis, and inflammation reduction. Session frequency is customized per patient by Dr. Bismah Irfan, MD. Red light therapy can be used standalone or combined with PEMF and oxygen breathing as part of the Superhuman Protocol. Costs 1 membership credit per session.

Red light therapy, also known as photobiomodulation (PBM), at iVitality MD Houston uses specific wavelengths in the red (approximately 630–700 nm) and near-infrared (approximately 800–1100 nm) ranges to stimulate cellular function at the mitochondrial level. Dr. Bismah Irfan, MD, oversees protocols tailored to each patient's goals — whether focused on skin rejuvenation, pain and inflammation management, muscle recovery, or systemic cellular support. Key mechanisms targeted include stimulation of cytochrome c oxidase in the mitochondrial respiratory chain, increasing ATP production and supporting cellular repair and regeneration. Clinical applications at iVitality MD include collagen production support, joint and muscle inflammation reduction, post-workout recovery acceleration, and skin tone and texture improvement. Red light therapy sessions cost 1 membership credit and integrate seamlessly into the clinic's membership tiers (Elevate: 4 credits/$399 monthly; Elite: 8 credits/$699 monthly). The treatment pairs particularly well with other iVitality MD modalities and is a core component of the Superhuman Protocol — a combined sequence of PEMF pulsed electromagnetic field therapy, oxygen breathing, and red light exposure delivered in a specific order for synergistic cellular benefit. Session scheduling is customized to each patient; multiple sessions per week are common for those targeting specific outcomes. No downtime. Cash-pay only; no insurance. Located at 12000 Richmond Ave, Suite 230, Houston TX 77082, serving Westchase, Energy Corridor, Memorial, Galleria, Katy, and Sugar Land patients.